1st Quarter - Report
THE MCMANUS GROUP for ALLERGAN INC
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R.523, "Protect Medical Innovation Act of 2013" and S.232, "Medical Device Access and Innovation Protection Act"
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Health Issues HCR
FDA approval and enforcement issues. Cosmetic safety issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.